8-K current report · filed Nov 9, 2026

Surgery Partners, Inc. (SGRY) 8-K Current Report: November 9, 2026

Item 1.01Item 7.01Item EX-99.1SGRY overview

Short answer

Surgery Partners, Inc. (SGRY) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Merger consideration raised to $25.00 per share in cash, improving shareholder economics.

Surgery Partners, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Merger consideration raised to $25.00 per share in cash, improving shareholder economics
  • 10% annual ticking fee after March 1, 2027 if approval is obtained but closing is delayed, capped at $1.61 per share
  • Parent faces broader antitrust-remediation obligations, reducing regulatory execution flexibility
  • Company termination fee increased to approximately $149.1 million, discouraging competing proposals
  • Superior-proposal termination before shareholder approval requires reimbursement of buyer expenses up to $8.25 million

Item 7.01 · Regulation FD Disclosure

  • Press release announces entry into an Amendment, making the revised agreement the key investor focus
  • Exhibit 99.1 contains the amendment announcement and likely substantive terms

Item EX-99.1 · Exhibit EX-99.1

  • Amended HealthSpan merger raises consideration to $25 per share, valuing Surgery Partners at up to approximately $6.0 billion enterprise value
  • Ticking Fee adds up to $1.61 per share if approval occurs before March 1, 2027 but closing extends to October 23, 2027
  • Competing third-party proposal offered $28 per share, but the Special Committee rejected it as not a Superior Proposal due to greater timing and regulatory risks
  • Bain Capital owns approximately 39% and remains committed to voting for HealthSpan, but will roll over its shares without receiving merger consideration
  • Closing remains targeted for the first quarter of 2027, subject to shareholder and regulatory approvals

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Surgery Partners, Inc. 8-K filings

Get the next SGRY 8-K as it lands

Follow SGRY for push alerts, or ask the research agent what this filing means.